CoBioRes: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CoBioRes
Largest movements
- Receivables within one year -€112,146
down €112,146 (-55.7%), from €201,248 to €89,102
of which Other amounts receivable: -€112,082
- Cash +€83,568
up €83,568 (+50.6%), from €165,215 to €248,783
mainly Receivables within one year (+€112,146) and Smaller working-capital items (+€248)
- Profit (loss) carried forward -€28,826
down €28,826 (-0.4%), from -€7.6m to -€7.7m
- Gross operating margin -€18,112
down €18,112 (-177%), from -€10,249 to -€28,361
- Taxes +€1,081
no longer reported in 2025 (was -€1,081)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €366,593 | €338,014 | -€28,579 | -7.8% |
| Current assets | 29/58 | €366,593 | €338,014 | -€28,579 | -7.8% |
| Amounts receivable within one year | 40/41 | €201,248 | €89,102 | -€112,146 | -55.7% |
| Trade receivables | 40 | €1,980 | €1,916 | -€64 | -3.2% |
| Other amounts receivable | 41 | €199,268 | €87,186 | -€112,082 | -56.2% |
| Cash at bank and in hand | 54/58 | €165,215 | €248,783 | +€83,568 | +50.6% |
| Deferred charges and accrued income | 490/1 | €130 | €129 | -€1 | -0.8% |
| Total equity and liabilities | 10/49 | €366,593 | €338,014 | -€28,579 | -7.8% |
| Equity | 10/15 | €366,593 | €337,767 | -€28,826 | -7.9% |
| Contributions | 10/11 | €8,000,000 | €8,000,000 | = | 0.0% |
| Capital | 10 | €8,000,000 | €8,000,000 | = | 0.0% |
| Issued capital | 100 | €8,000,000 | €8,000,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€7,633,407 | -€7,662,233 | -€28,826 | -0.4% |
| Amounts payable | 17/49 | - | €247 | +€247 | |
| Amounts payable within one year | 42/48 | - | €247 | +€247 | |
| Trade debts | 44 | - | €247 | +€247 | |
| Suppliers | 440/4 | - | €247 | +€247 | |
| Non-recurring operating income | 76A | €289 | - | -€289 | |
| Gross operating margin | 9900 | -€10,249 | -€28,361 | -€18,112 | -177% |
| Operating profit (loss) | 9901 | -€10,249 | -€28,361 | -€18,112 | -177% |
| Financial charges | 65/66B | €490 | €466 | -€24 | -4.9% |
| Recurring financial charges | 65 | €490 | €466 | -€24 | -4.9% |
| Profit (loss) for the period before taxes | 9903 | -€10,739 | -€28,827 | -€18,088 | -168% |
| Income taxes | 67/77 | -€1,081 | - | +€1,081 | |
| Profit (loss) for the period | 9904 | -€9,658 | -€28,827 | -€19,169 | -198% |
| Profit (loss) for the period to be appropriated | 9905 | -€9,658 | -€28,827 | -€19,169 | -198% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.